|
4,6-dimethyl-N-[(Z)-1-pyridin-2-ylethylideneamino]pyrimidin-2-amine |
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
5,7-diiodo-1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-8-ol |
Depiction based on curated SMILES
OH
I
I
N
H
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
5,7-dinitroquinolin-8-ol |
Depiction based on curated SMILES
_
O
N
OH
O
O
+
N
_
O
+
N
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
Diethyl 6-bromo-2,4-quinolinedicarboxylate |
Depiction based on curated SMILES
H
3
C
O
O
Br
CH
3
N
O
O
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
2-(4-tert-Butyl-phenoxymethyl)-4-hydroxy-pyrimidine-5-carboxylic acid ethyl ester |
Depiction based on curated SMILES
CH
3
H
3
C
H
3
C
O
CH
3
O
HN
N
O
O
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
(2R,3S,4S,5S,6R)-2-[(R)-hydroxy-(4-isoquinolin-5-yl-2-methylphenyl)methyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
Depiction based on curated SMILES
HO
OH
OH
OH
O
HO
H
CH
3
N
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
(2R,3S,4S,5S,6R)-2-[(R)-[4-(1-aminoisoquinolin-7-yl)-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
Depiction based on curated SMILES
HO
OH
OH
OH
O
HO
H
CH
3
NH
2
N
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-amine |
Depiction based on curated SMILES
NH
2
N
B
CH
3
CH
3
CH
3
H
3
C
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2H-isoquinolin-1-one |
Depiction based on curated SMILES
HO
OH
OH
OH
O
HO
H
CH
3
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-3,4-dihydro-2H-isoquinolin-1-one |
Depiction based on curated SMILES
HO
OH
OH
OH
O
HO
H
CH
3
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
| | |